More on NVTA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.02 |
|
|||
| Open | $0.02 | ||||
| 52 Wk High | $11.85 | ||||
| 52 Wk Low | $5.66 | ||||
| Day High | $0.02 | ||||
| Day Low | $0.02 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 35,379 | ||||
- Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
- Form 8-K Invitae Corp For: Mar 29
- Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
- Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
- Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting
- Form 25-NSE Invitae Corp Filed by: NEW YORK STOCK EXCHANGE LLC
- Form 8-K Invitae Corp For: Feb 13
- InVitae (NVTA) Files for Chapter 11
- Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
- Form SC 13G/A Invitae Corp Filed by: VANGUARD GROUP INC
Entities mentioned with NVTA
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Cowen & Co | View Related Stories »
- FDA | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
